Services Database Take Home Naloxone (Derby City Area)

Service ID

521282

Description

Service Description

The following elements of service delivery will align to the objectives in Section 1.2.

In delivering this service the Provider will demonstrate compliance with all relevant national standards for service quality and clinical governance including compliance with their obligations under Schedule 4 of the Pharmaceutical Services Regulations (Terms of Service of NHS pharmacists) in respect of the provision of essential services and an acceptable system of clinical governance.

The community pharmacy take home naloxone service will be offered to suitable substance misuse needle exchange clients. The service will:

  • Offer a user friendly, non-judgemental, client centred and confidential service.
  • Offer Naloxone to anyone who is:
  • Currently using illicit opiates such as heroin
  • Receiving opioid substitution therapy
  • Leaving prison/rehab with a history of drug use
  • Who has previously used opiate drugs (to protect in the event of a relapse)
  • Offer Naloxone to a family member, carer, peer or friend of anyone identified above with consent.
  • Provide those offered naloxone with brief training in recognising the symptoms of opioid overdose, how to respond appropriately (including CPR and the recovery position) and how to administer naloxone.
  • Facilitate access to substance misuse treatment and other health and welfare services as appropriate.
  • Adhere to all policies relating to the safeguarding of vulnerable adults and children.

There are two formulations of naloxone suitable for use in the home and non-medical setting, and therefore can be used to supply as part of the take home naloxone programme for use in an emergency:

  • Prenoxad® solution for Injection - Each kit contains 1 x 2ml pre-filled syringe (Naloxone Hydrochloride 1.0mg/1ml) and 2 x 23G 1.25” needles for intramuscular injection.
  • Nyxoid® Nasal Spray – Each spray contains 1.8mg naloxone hydrochloride. It is a single use product, the recommended dose being one spray (1.8mg) into the nostril. Each pack contains two individually sealed nasal sprays.

Either can be issued as part of this service specification.

Location of service

Derbyshire LPC

Commissioner

Local Authority (LA)

Method of commissioning

Source of funding

Service type

Naloxone

Other organisations involved

Dates

Start date:
End date:

Status

Ongoing

Training

The pharmacy must ensure that all pharmacy based staff delivering needle exchange and take home naloxone interventions have relevant knowledge and are appropriately accredited in drug awareness, impacts of substance misuse, blood borne viruses, safeguarding, client centred communications skills, data protection and confidentiality.

Staff supplying naloxone should have been appropriately trained and all staff should

Complete the Addiction Professionals Educational Resources FreeLearn: Naloxone Saves Lives online learning package https://www.ap-elearning.org.uk/

Comments